Pfizer is set to defend itself in Texas trial over the company's hormone-replacement drugs after a court overseeing lawsuits over the medicines sent 200 cases back to their home courts.
A judge in Galveston, Texas, set a 2011 trial date for Karen Zahn’s claims against Pfizer’s Wyeth unit. Zahn says in her suit that the Prempro menopause drug helped cause her breast cancer. There are more than 8,000 lawsuits over the medicine consolidated in federal court in Arkansas to be returned for trial.
More than 6 million women took the menopause drugs to treat symptoms such as hot flashes and mood swings before a 2002 study highlighted their links to cancer. Wyeth’s sales of the medicines, which are still on the market, topped $2 billion before the Women’s Health Initiative study concluded they posed an increased breast-cancer risk.